Peer-reviewedCC BY-NCOxford medical case reports
Successful management of high-risk proliferative diabetic retinopathy during pregnancy with intravitreal faricimab
Related
- Comparison of Intravitreal Antivascular Endothelial Growth Factor Therapy in Treatment-Naïve vs Panretinal Photocoagulation–Treated Eyes With Proliferative Diabetic Retinopathy
- Association between the stress hyperglycemia ratio and neovascular glaucoma in patients with proliferative diabetic retinopathy
- Visual Acuity Outcomes in Socioeconomically Disadvantaged Patients With Vitreous Hemorrhage Resulting From Proliferative Diabetic Retinopathy Treated at a County Hospital
- Stimulus-Induced Histone H3 Citrullination and Neutrophil Extracellular Trap Formation Are Impaired in Patients with Proliferative Diabetic Retinopathy
- Intravitreal methotrexate as a prophylactic strategy for proliferative vitreoretinopathy in high-risk retinal detachment.
BibTeX
@article{anon2026successful,
title = {{Successful management of high-risk proliferative diabetic retinopathy during pregnancy with intravitreal faricimab}},
journal = {Oxford medical case reports},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13676271},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - Successful management of high-risk proliferative diabetic retinopathy during pregnancy with intravitreal faricimab
PY - 2026
DA - 2026/10/01
JO - Oxford medical case reports
UR - https://europepmc.org/article/PMC/PMC13676271
SN - 2053-8855
ER -